Analyst Price Target is GBX 77
▲ +15.27% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for NIOX Group in the last 3 months. The average price target is GBX 77, with a high forecast of GBX 77 and a low forecast of GBX 77. The average price target represents a 15.27% upside from the last price of GBX 66.80.
Current Consensus is
Buy
The current consensus among 1 investment analysts is to buy stock in NIOX Group. This Buy consensus rating has held steady for over two years.
NIOX Group
NIOX Group Plc, engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo), a biomarker for asthma worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Read More